BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3037035)

  • 1. The correlation of neoplastic vulnerability with central neuroepithelial cytogeny and glioma differentiation.
    Rubinstein LJ
    J Neurooncol; 1987; 5(1):11-27. PubMed ID: 3037035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.
    Rubinstein LJ
    J Neurosurg; 1985 Jun; 62(6):795-805. PubMed ID: 2987439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases.
    Bonnin JM; Rubinstein LJ; Palmer NF; Beckwith JB
    Cancer; 1984 Nov; 54(10):2137-46. PubMed ID: 6091860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.
    Katsetos CD; Legido A; Perentes E; Mörk SJ
    J Child Neurol; 2003 Dec; 18(12):851-66; discussion 867. PubMed ID: 14736079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is polar spongioblastoma a tumor entity?
    Schiffer D; Cravioto H; Giordana MT; Migheli A; Pezzulo T; Vigliani MC
    J Neurosurg; 1993 Apr; 78(4):587-91. PubMed ID: 8450332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid anaplastic transformation of gliomas in childhood.
    Schmitt HP
    Neuropediatrics; 1983 Aug; 14(3):137-43. PubMed ID: 6621805
    [No Abstract]   [Full Text] [Related]  

  • 8. Apoptosis and cell proliferation in human neuroepithelial tumors.
    Schiffer D; Cavalla P; Migheli A; Chiò A; Giordana MT; Marino S; Attanasio A
    Neurosci Lett; 1995 Aug; 195(2):81-4. PubMed ID: 7478273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects.
    Budka H
    Acta Neurochir Suppl (Wien); 1985; 35():23-30. PubMed ID: 3004117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and Genetics of Gliomas.
    Komori T; Muragaki Y; Chernov MF
    Prog Neurol Surg; 2018; 31():1-37. PubMed ID: 29393190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
    Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].
    Feiden S; Feiden W
    Pathologe; 2008 Nov; 29(6):411-21. PubMed ID: 18820922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cultures of tissue from central nervous system tumors. Part 1. Neuroglial tumors].
    de Tribolet N; Martin-Achard A; Diserens AC; Schnegg JF; Zander E
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(1):59-71. PubMed ID: 545689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
    Deckert M; Reifenberger G; Wechsler W
    J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primitive neuroectodermal tumors of the central nervous system.
    Becker LE; Hinton D
    Hum Pathol; 1983 Jun; 14(6):538-50. PubMed ID: 6303940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.